LN 3R70-01; software version 2.6.2 and earlier. The software is used with the Alinity i (LN 03R65-01) processing module and the Alinity c (LN 03R67-01) processing module.
Published April 1, 2020 · Recall initiated: January 24, 2020
Summary
FDA records medical device Class II recall Z-1580-2020, published April 1, 2020 and initiated January 24, 2020. Recalling firm: Abbott Gmbh & Co. KG; Status: Terminated; Reported quantity: 2676 units; Lot: LN 3R70-01; software version 2.6.2 and earlier. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Abbott has identified potential performance issues for the Alinity ci -series Software version 2.6.2 and earlier.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abbott Gmbh & Co. KG
- Distributor
- Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, FL, GA, ID, IL, LA, MA, MD, ME, MI, MN, MC, MS, NC, NJ, NY, OK, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV and countries of Albania, Argentina, Australia, Austria, Bahrain, Bangledesh, Belgium, Bermuda, Bosnia, Botswana, Brazil, Bulgaria, Burkina Faso, Canada, Chile, China, Columbia, Costa Rica, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Madagascar, Malaysia, Mexico, Namibia, Netherlands, New Caledonia, New Zealand, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Trinidad and Tobago Turkey, UEA, UK, Ukraine, Uruguay, Vietnam.
- Lot
- LN 3R70-01; software version 2.6.2 and earlier.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Germany
Related recalls
- FDAPowerFlow Implatable Apheresis IV Port with attachable 9.6 F ChronoFl x Open-Ended Single-Lumen VenousApril 1, 2020
- FDAMiniMed Insulin Pump, model # MMT-508April 1, 2020
- FDA1. X-Port isp M.R.I Implantable Port, with Pre-Attached 9.6 F Open-Ended Single-Lumen Venous Catheter,April 1, 2020
- FDAARCHITECT HAVAB-G Calibrator, REF 6L27-01December 4, 2019
- FDAAlinity i Processing Module, 03R65 01, with the below components. a. TED (Thermo Electric Device) Engine,June 5, 2019
- FDAAbbott Alinity ci-series System Control Module software version 2.5.1; LN 3R70-01 with the following hardware:May 22, 2019
Questions about this recall
Was LN 3R70-01; software version 2.6.2 and earlier. The software is used with the Alinity i (LN 03R65-01) processing module and the Alinity c (LN 03R67-01) processing module. recalled?
Yes. FDA published recall Z-1580-2020 on April 1, 2020. Reported hazard: Abbott has identified potential performance issues for the Alinity ci -series Software version 2.6.2 and earlier.
What should I do if I have this product?
Voluntary: Firm initiated · Letter